Epstein-Barr virus (EBV) is associated with nasopharyngeal carcinoma (NPC). We assess the safety and tolerability of adoptive transfer of autologous cytotoxic T lymphocytes (CTLs) specific for the EBV latent membrane protein (LMP) in a patient with recurrent NPC. After infusion, the majority of pulmonary lesions were no longer evident, although the primary tumor did not regress.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3910937 | PMC |
| http://dx.doi.org/10.1128/CVI.00121-13 | DOI Listing |
Publication Analysis
Top Keywords
nasopharyngeal carcinoma
8
cytotoxic cell
4
cell adoptive
4
adoptive immunotherapy
4
immunotherapy treatment
4
treatment nasopharyngeal
4
carcinoma epstein-barr
4
epstein-barr virus
4
virus ebv
4
ebv associated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!